Article
Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice.
PloS one - 1 Jan 2014
Zafra Ma Paz, Mazzeo Carla, Gámez Cristina, Rodriguez Marco Ainara, de Zulueta Ana, Sanz Veronica, Bilbao Izaskun, Ruiz-Cabello Jesús, Zubeldia Jose M, del Pozo Victoria
Abstract excerpt
Suppresors of cytokine signaling (SOCS) proteins regulate cytokine responses and control immune balance. Several studies have confirmed that SOCS3 is increased in asthmatic patients, and SOCS3 expression is correlated with disease severity. The objective of this study was to evaluate if delivering of SOCS3 short interfering RNA (siRNA) intranasally in lungs could be a good therapeutic approach in an asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
